Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel reductive amination route for PARP inhibitor intermediate TSL-1502M ensures high purity and scalable manufacturing for global supply chains.
Patent CN107089979B reveals improved synthesis for Palonosetron Hcl. Enhanced yield and simplified chiral control offer supply chain stability.
Novel deuterated Palbociclib derivative patent CN106967064A offers improved metabolic stability and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103664773A reveals a water-based purification method for Milrinone, reducing costs and improving purity for cardiovascular API manufacturing.
Patent CN1277807C details a novel metal hydride reduction route for carbocyclic nucleoside intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel patent CN105153124B offers milder conditions and higher purity for Candesartan Cilexetil manufacturing, ensuring supply chain reliability.
Novel synthetic route for ulipristal acetate avoids toxic reagents. High yield, scalable process for reliable API intermediate supply chain.
Novel water-based oxidation of kungfu acid yields high-purity caronic acid. Safe, scalable process reduces cost in API manufacturing for HCV inhibitors.
Patent CN105130898A enables visible-light synthesis of gem-difluoro polycyclic compounds. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN115073373A details a high-yield asymmetric synthesis route for (R)-5'-methoxylaudanosine, eliminating genotoxic impurities and reducing costs for muscle relaxant manufacturing.
Patent CN101289417B details an advanced purification process for D-3-thioacetyl-2-methylpropionyl-L-proline, offering superior yield and optical purity for captopril manufacturing.
Patent CN103724323B offers catalyst-free cyclization for high-purity Pomalidomide. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN117624265A details efficient synthesis of Etogliflozin impurities. Enhances quality control and offers cost reduction in API manufacturing for global supply chains.
Patent CN117105802B enables one-step amino alcohol synthesis. Reduces complexity in pharmaceutical intermediates manufacturing with high purity and green conditions.
Patent CN110177790B details a scalable resolution process for diazaspiro[4.5]decane derivatives, offering high enantiomeric excess and cost-effective manufacturing for pharmaceutical intermediates.
Novel POCl3 method achieves >99.5% purity. Reduces impurities vs SOCl2 route. Ideal for pharma scale-up and cost reduction.
Patent CN114014912B reveals hybrid solid-liquid phase synthesis improving purity and yield. This method offers significant supply chain reliability and cost reduction advantages for pharmaceutical manufacturing.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Patent CN116239552B reveals a magnesium-catalyzed route for empagliflozin intermediates. This method offers significant supply chain stability and cost reduction potential for pharmaceutical manufacturing.
Advanced preparation method for Pioglitazone Related Substance D ensuring high purity. Optimized synthetic route for pharmaceutical quality control and reference standards.